Cough News and Research

RSS

Study explores long COVID in adults

A new study reviewed post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS) in the adult population.

4 May 2022

Phase 2 clinical trial of COVID-19 convalescent plasma with high antibody titers

Researchers determined the threshold neutralizing antibody titer for effective COVID-19 convalescent plasma therapy.

4 May 2022

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Researchers reviewed the potential clinically relevant mechanisms by which microbiota and microbiota-derived metabolites influence the host immune responses to SARS-CoV-2 infection.

3 May 2022

Estimating COVID-19 case prevalence in New York City

Researchers estimated the prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in New York City (NYC).

2 May 2022

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Researchers examined the characteristics and outcomes of COVID-19 in immunocompromised patients.

29 Apr 2022

Durability and neutralization capacity of SARS-CoV-2 specific antibodies in the breastmilk of convalescent COVID-19 mothers

The researchers assessed immunological and pathophysiological aspects of antenatal COVID-19.

26 Apr 2022

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

T cell responses were measured to three SARS-CoV-2-associated antigens, as well as the endemic coronaviruses HCoV-OC43 and HCoV-NL63.

25 Apr 2022

Discovering Genetic Variants that Significantly Predispose People to Critical COVID-19

We speak with postdoctoral researcher Erola Pairo-Castineira about her recent work which aimed to find the genetic factors that may predispose individuals to critical COVID-19 and learn how COVID-19 affects cells in the body.

22 Apr 2022

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Researchers investigate the rates at which different pathogens appear in children, both independently and alongside SARS-CoV-2.

21 Apr 2022

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Researchers investigated the effect of binding antibodies on SARS-CoV-2 Omicron breakthrough infections.

21 Apr 2022

Waning antibody responses in SARS-CoV-2-infected children and adults over time

In a new study, researchers evaluated the duration of antibodies against SARS-CoV-2.

20 Apr 2022

Wearables can identify changes in physiological systems during COVID-19 disease progression

If you become ill with COVID-19, your smartwatch can track the progression of your symptoms, and could even show how sick you become.

19 Apr 2022

Two strains of TB bacterium attack the lungs in completely different fashion, study finds

Two strains of the bacterium causing tuberculosis have only minor genetic differences but attack the lungs in completely different fashion, according to Rutgers researchers.

18 Apr 2022

AI can help identify which symptoms are more likely to indicate COVID during flu season

Testing shortages, long waits for results, and an over-taxed health care system have made headlines throughout the COVID-19 pandemic.

13 Apr 2022

When symptoms linger for weeks, is it long covid?

Many Americans are discovering that recovering from covid-19 may take weeks or even months longer than expected, leaving them with lingering symptoms like intense fatigue or a racing pulse. But does that mean they have what's known as long covid?

13 Apr 2022

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

A recent scientific statement published in Circulation reviewed the current knowledge on COVID-19.

13 Apr 2022

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

A recent study assessed the efficacy of the second and third doses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccines against the SARS-CoV-2 Omicron and Delta variants in outpatient settings.

13 Apr 2022

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

A recent study assessed the prevalence of SARS-CoV-2 symptoms and the risk of hospitalization in vaccinated individuals infected with SARS-CoV-2 Omicron and Delta variants.

12 Apr 2022

Immunocompromised hosts with Delta/Omicron co-infections

A recent study posted to the medRxiv* preprint server examined clinical cases of co-infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta/Omicron variants and Omicron BA.1/ BA.2 sublineages in immunocompromised (IC) patients.

10 Apr 2022

The dynamics of the Omicron wave in England

Researchers investigated the transmission dynamics of SARS-CoV-2 VOC Omicron in England using PCR testing and genomic sequencing data from the REACT-1 study.

7 Apr 2022

Cough News and Research

Study explores long COVID in adults

Phase 2 clinical trial of COVID-19 convalescent plasma with high antibody titers

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Estimating COVID-19 case prevalence in New York City

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Durability and neutralization capacity of SARS-CoV-2 specific antibodies in the breastmilk of convalescent COVID-19 mothers

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

Discovering Genetic Variants that Significantly Predispose People to Critical COVID-19

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Waning antibody responses in SARS-CoV-2-infected children and adults over time

Wearables can identify changes in physiological systems during COVID-19 disease progression

Two strains of TB bacterium attack the lungs in completely different fashion, study finds

AI can help identify which symptoms are more likely to indicate COVID during flu season

When symptoms linger for weeks, is it long covid?

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

Immunocompromised hosts with Delta/Omicron co-infections

The dynamics of the Omicron wave in England

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News